BENATI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 5.542
EU - Europa 2.592
AS - Asia 2.486
SA - Sud America 398
Continente sconosciuto - Info sul continente non disponibili 113
AF - Africa 66
OC - Oceania 31
Totale 11.228
Nazione #
US - Stati Uniti d'America 5.421
IT - Italia 868
SG - Singapore 715
CN - Cina 629
GB - Regno Unito 589
HK - Hong Kong 334
BR - Brasile 291
VN - Vietnam 276
SE - Svezia 214
DE - Germania 190
BD - Bangladesh 164
FR - Francia 145
RU - Federazione Russa 126
FI - Finlandia 95
UA - Ucraina 94
KR - Corea 75
NL - Olanda 68
CA - Canada 60
IN - India 57
ID - Indonesia 37
AR - Argentina 33
BG - Bulgaria 33
AU - Australia 31
TR - Turchia 31
MX - Messico 30
JP - Giappone 28
IQ - Iraq 26
IE - Irlanda 24
BE - Belgio 23
ZA - Sudafrica 21
ES - Italia 17
CH - Svizzera 16
CO - Colombia 16
LT - Lituania 16
EC - Ecuador 14
PK - Pakistan 14
AT - Austria 13
VE - Venezuela 13
AE - Emirati Arabi Uniti 12
CZ - Repubblica Ceca 12
TN - Tunisia 12
MY - Malesia 11
NP - Nepal 11
CL - Cile 10
JO - Giordania 10
MA - Marocco 10
PL - Polonia 9
SA - Arabia Saudita 9
CR - Costa Rica 8
AL - Albania 7
DK - Danimarca 7
PY - Paraguay 7
UY - Uruguay 7
DZ - Algeria 6
IL - Israele 6
PH - Filippine 6
IR - Iran 5
JM - Giamaica 5
KE - Kenya 5
PE - Perù 5
TW - Taiwan 5
BY - Bielorussia 4
PR - Porto Rico 4
TH - Thailandia 4
BZ - Belize 3
EG - Egitto 3
ET - Etiopia 3
GR - Grecia 3
GT - Guatemala 3
KZ - Kazakistan 3
LV - Lettonia 3
PT - Portogallo 3
QA - Qatar 3
RO - Romania 3
RS - Serbia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HR - Croazia 2
LK - Sri Lanka 2
MD - Moldavia 2
NG - Nigeria 2
PS - Palestinian Territory 2
AG - Antigua e Barbuda 1
AW - Aruba 1
BW - Botswana 1
CI - Costa d'Avorio 1
EU - Europa 1
HU - Ungheria 1
KG - Kirghizistan 1
LB - Libano 1
LY - Libia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
MQ - Martinica 1
NI - Nicaragua 1
PA - Panama 1
Totale 11.113
Città #
Ashburn 599
Santa Clara 569
Singapore 494
Fairfield 473
Southend 362
Hong Kong 323
San Jose 293
Chandler 261
Woodbridge 217
Houston 202
Seattle 173
Wilmington 166
Nyköping 164
Cambridge 158
Hefei 156
Dearborn 148
Jacksonville 146
Council Bluffs 141
Beijing 132
London 114
Bologna 107
Ho Chi Minh City 90
Ann Arbor 89
Helsinki 87
New York 81
Los Angeles 79
Modena 73
The Dalles 71
Seoul 61
Milan 60
Hanoi 53
San Diego 53
Chicago 50
Lauterbourg 41
Princeton 40
Dallas 35
Orem 35
Columbus 34
Sofia 33
Eugene 31
Moscow 31
Munich 30
Buffalo 29
Shanghai 28
Jakarta 26
Rome 25
São Paulo 24
Parma 22
Brussels 21
Falls Church 20
Queens 19
Toronto 19
Atlanta 18
Boardman 18
Paris 18
Tokyo 18
Dublin 17
Izmir 17
Phoenix 17
Redondo Beach 17
Bremen 16
Naples 15
Salt Lake City 15
Amsterdam 14
Haiphong 14
Nuremberg 14
Redwood City 14
San Francisco 14
Tampa 14
Da Nang 13
Montreal 13
Portsmouth 13
Reggio Emilia 13
Adelaide 11
Boston 11
Brooklyn 11
Mexico City 11
Rio de Janeiro 11
Chennai 10
Guangzhou 10
Turin 10
Wuhan 10
Amman 9
Brno 9
Elk Grove Village 9
Hải Dương 9
Johannesburg 9
Miano 9
Mumbai 9
Piacenza 9
Stockholm 9
Vienna 9
Brasília 8
Denver 8
Des Moines 8
Dong Ket 8
Napoli 8
Padua 8
Palermo 8
Trento 8
Totale 7.359
Nome #
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 462
CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient 440
CRISPR/Cas9-mediated specific knock-down of dominant mutations in Rhodopsin gene 419
CRISPR/Cas9 gene editing in vitro and in retinal cells in vivo 387
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 341
In vitro and in vivo CRISPR/Cas9-mediated genome editing to downregulate dominant mutations in Rhodopsin gene 300
An efficient in vitro transposition method by a transcriptionally regulated sleeping beauty system packaged into an integration defective lentiviral vector 299
Altered Responses to Homeostatic Cytokines in Patients with Idiopathic CD4 Lymphocytopenia 295
CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers 285
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 283
DNA vaccination by electroporation amplifies broadly cross-restricted public TCR clonotypes shared with HIV Controllers 276
The shc family protein adaptor, Rai, negatively regulates T cell antigen receptor signaling by inhibiting ZAP-70 recruitment and activation 264
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 261
A High Frequency of HIV-Specific Circulating Follicular Helper T Cells Is Associated with Preserved Memory B Cell Responses in HIV Controllers 260
Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model 251
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 249
CRISPR/Cas9 Allele-Specific Design To Inactivate A Dominant-Negative Mutation In COL6A1 Causing Ullrich Muscular Dystrophy 239
Gene editing prospects for treating inherited retinal diseases 234
Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases 232
Public T cell receptors confer high-avidity CD4 responses to HIV controllers 230
Engineered Sleeping Beauty Transposon as Efficient System to Optimize Chimp Adenoviral Production 229
HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term 227
Simvastatin impairs humoral and cell-mediated immunity in mice by inhibiting lymphocyte homing, T-cell activation and antigen cross-presentation 225
The strepsipteran endoparasite Xenos vesparum alters the immunocompetence of its host, the paper wasp Polistes dominulus 221
Comparison of the antigen sensitivity of Gag-specific CD4+ T cell responses in controlled HIV infection and HIV vaccination 221
MHC Class II Tetramer Labeling of Human Primary CD4+ T Cells from HIV Infected Patients 217
Bcr-Abl stabilizes β-catenin in chronic myeloid leukemia through its tyrosine phosphorylation 211
T cell receptors from the HIV-specific repertoire, means for their production and therapeutic uses thereof 208
Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus 198
Characterization of high avidity CD4+ T cells in HIV Controllers 197
SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of β-catenin and its nuclear signaling 194
SRC family kinases as potential therapeutic targets for malignancies and immunological disorders 194
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 186
Specific cTfh frequency correlates with memory B cell responses in HIV controllers. 184
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 177
Efficient CRISPR/Cas9-Mediated iIn Situ Correction of LAMB3 Gene in Keratinocytes Derived from Junctional Epidermolysis Bullosa Patient 174
Public TCRs confer high-avidity CD4 responses to HIV controllers 172
HIV Controller CD4+ T cells preferentially express a public TCR clonotype that confers high avidity responses against Gag 169
CRISPR/Cas9 allele-specifc design to inactivate a dominant-negative mutation in COL6A1 causing Ullrich muscular dystrophy. 168
Frequent sharing of high-affinity TCRs in naturally controlled HIV infection: implications for vaccination 166
Molecular characterization of high avidity CD4+ T cells in HIV Controllers 164
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 164
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 160
Specific Knock-down of P347S Dominant Mutation in Rhodopsin Gene by CRISPR/Cas9 System 158
Restored Collagen VI Microfilaments Network in the Extracellular Matrix of CRISPR-Edited Ullrich Congenital Muscular Dystrophy Fibroblasts 149
Induced Pluripotent Stem Cells and Genome-Editing Tools in Determining Gene Function and Therapy for Inherited Retinal Disorders 149
Specific knock-down of C-terminal dominant mutation in Rhodopsin gene by CRISPR/Cas9 system 138
Erratum: Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases (European Journal of Immunology (2006) vol. 36 (11) 10.1002/eji.200636567)) 133
Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts 68
Totale 11.228
Categoria #
all - tutte 44.074
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.074


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022652 0 0 61 23 42 47 55 40 85 59 148 92
2022/20231.005 108 102 98 87 123 115 29 69 125 19 64 66
2023/2024671 32 53 55 64 94 30 48 85 20 32 59 99
2024/20252.027 64 40 76 121 373 315 169 127 215 130 173 224
2025/20263.568 238 103 260 419 523 236 432 157 380 313 266 241
2026/2027439 120 302 17 0 0 0 0 0 0 0 0 0
Totale 11.228